ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1144

Wnt Signaling Pathway Regulates Multi-Unconventional Differentiation and Function Of Human Dendritic Cells

Jia Wang1, Yi Liu2 and Yi Zhao2, 1General medical center, Sichuan Provincial People's Hospital, Chengdu, China, 2Department of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu, China

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: dendritic cells and immune tolerance, WNT Signaling

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Innate Immunity and Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Dendritic cells (DCs) play a central role in regulating immune responses and govern T cell priming and polarization, mediating immunity and tolerance. Recent progress uncovered the Wnt signaling pathway is crucial for the immune balance and focuses on DCs as a direct target for their immunoregulatory role. In this study, we investigated the effect of the canonical and non-canonical Wnt signaling pathways regulate the differentiation and function of human DCs.

Methods:

Human peripheral blood CD14+ monocytes were cultured for 6 days with GM-CSF/IL-4 and then treated with LPS, Wnt3a, Wnt5a, GSK-3b inhibitor (SB216763) or silencing b-catenin for 24 h. Immunophenotypic characterizations of DCs were analyzed by flow cytometry. The supernatants were collected and cytokines (IL-17, IL-23, IL-10, TNF-¦Á, IFN-¦Ã) were assessed. Human peripheral blood and active rheumatoid arthritis patients’ synovial fluid CD3+ monocytes were isolated for mixed lymphocyte reaction. Proteins were extracted and incubated with antibodies against the total or phosphorylated forms of b-catenin, GSK-3b.

Results:

Our results showed that regulating the canonical and non-canonical Wnt signaling altered the maturation status and function of already differentiated DCs. The differentiation of DCs resulted in inhibiting activity of GSK-3b and stabilizing its substrate, b-catenin. GSK-3b inhibitor induced a full maturation phenotype of DCs that expressed mostly CD14. These DCs produced low levels of IL-17, IL-23 but high level of IL-10. Consequently, these DCs have a reduced capacity to stimulate Th17 differentiation and increased Th2 and Treg differentiation. The addition of Wnt3a or Wnt5a both increased CD1a+DCs but reduced CD83, CD80, CD86, CD40 and HLA-DR expression. Wnt3a-DCs produce scant amounts of cytokines and have a reduced capacity to stimulate all T cell subsets differentiation. Wnt5a-DCs produced low level of IL-17, TNF-¦Á while increased IL-23, IL-10 secretion and have an increased capacity to stimulate Th2 and Treg differentiation. b-catenin silencing reduced CD83 expression on LPS-induced DCs maturation and IL-10 secretion, without significant effect on capacity of DCs to stimulate T cells differentiation.

Conclusion:

Wnt signaling pathway regulates multi-unconventional differentiation and function of human DCs. GSK-3b inhibitor could induce terminal differentiation DCs into unconventional phenotypic maturation of DCs with tolerogenic features. Silencing of b-catenin partly impair LPS induced maturation of DCs. Exogenous Wnt3a inhibited maturation and function of DCs while Wnt5a inhibited maturation of DCs with regulatory features.

 


Disclosure:

J. Wang,
None;

Y. Liu,
None;

Y. Zhao,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/wnt-signaling-pathway-regulates-multi-unconventional-differentiation-and-function-of-human-dendritic-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology